This Article Full Text Full Text (PDF) All Versions of this Article: 38/12/3193    most recent STROKEAHA.107.491423v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Rosengarten, B. Articles by Kaps, M. Search for Related Content PubMed PubMed Citation Articles by Rosengarten, B. Articles by Kaps, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL NITRIC OXIDE Related Collections Other Stroke Treatment - Medical Lipid and lipoprotein metabolism Endothelium/vascular type/nitric oxide Other Vascular biology Other diagnostic testing Emergency treatment of Stroke

(Stroke. 2007;38:3193.)
© 2007 American Heart Association, Inc.

Original Contributions

Effects of Initiation and Acute Withdrawal of Statins on the Neurovascular Coupling Mechanism in Healthy, Normocholesterolemic Humans

From the Departments of Neurology (B.R., M.K.) and Clinical Chemistry and Pathobiochemistry (D.A.), University Hospital Giessen and Marburg, Giessen, Germany.

Correspondence to Bernhard Rosengarten, MD, Department of Neurology, University Clinics of Giessen and Marburg, Am Steg 14, 35392 Giessen, Germany. E-mail bernhard.rosengarten{at}neuro.med.uni-giessen.de

Background and Purpose— Recent clinical trials imply increased risk of vascular events after statin withdrawal. There is evidence that this observation relates to an impaired nitric oxide system. The present analysis investigates the effect of initiation and withdrawal of statin therapy on resting and functionally activated cerebral hemodynamics in healthy young volunteers.

Methods— Sixteen healthy students (aged 23.7±3.3 years, 10 male) were subjected to a placebo-controlled, double-blind crossover study with a washout phase between blocks of 4 weeks. In the verum group, 20 mg pravastatin was taken for 2 weeks followed by 40 mg for 4 weeks. Withdrawal effects were investigated the day after discontinuation. Total cholesterol levels, blood pressure, resting and evoked hemodynamic responses due to a visual stimulation task in the posterior cerebral artery were obtained at baseline and then weekly and the day after discontinuation.

Results— In the verum group, cholesterol levels significantly decreased after 2 weeks (from 183±30 to 150±28 mg/dL; P<0.001) and then remained nearly stable (147±21 mg/dL after 6 weeks). Blood pressure, resting and evoked hemodynamic responses remained constant throughout the study. The day after statin withdrawal, evoked flow velocity responses were significantly lower (11±4% versus 13±5% at baseline; P<0.01) indicating inappropriate blood supply of active neurons.

Conclusions— Reduction in evoked flow velocity responses reflects reduced nitric oxide bioavailability and therefore supports molecular findings of acute statin withdrawal. Questions arise if the present data might give a link to reports of increased vascular events in patients at vascular risk after acute statin withdrawal.

Key Words: cerebral blood flow • endothelium • HMG-CoA reductase inhibitors • neurovascular coupling • nitric oxide